Book contents
- Frontmatter
- Contents
- List of contributors
- Preface
- Part I Basic skills
- Part II Common psychiatric problems across the general hospital
- Part III Working with specific units
- Part IV Treatment
- 33 Psychopharmacological treatment in liaison psychiatry
- 34 The role of psychological treatments
- 35 Problem cases
- Part V Different treatment settings
- Index
- References
33 - Psychopharmacological treatment in liaison psychiatry
from Part IV - Treatment
Published online by Cambridge University Press: 10 December 2009
Book contents
- Frontmatter
- Contents
- List of contributors
- Preface
- Part I Basic skills
- Part II Common psychiatric problems across the general hospital
- Part III Working with specific units
- Part IV Treatment
- 33 Psychopharmacological treatment in liaison psychiatry
- 34 The role of psychological treatments
- 35 Problem cases
- Part V Different treatment settings
- Index
- References
Summary
There is still limited systematic research on the effectiveness of psychotropic drugs used in liaison psychiatry settings. All drugs available in clinical psychiatry for the treatment of psychiatric disorders can be used in liaison settings. However, before choosing a specific drug, liaison psychiatrists must address additional important issues beyond those related to the indication for a psychotropic drug. Most psychotropic drugs used today are aimed at g-protein coupled receptors such as serotonergic (5HT). The availability of psychotropic drugs varies to some extent between countries within the European Union. This chapter discusses the most frequently used drugs. Depressive disorders accompanying physical illness should be treated to improve quality of life and treatment adherence. The main indications in liaison psychiatry settings are behavioural disorders caused by organic brain dysfunction including temporal lobe epilepsy, acute mania, pain disorders and prophylactic treatment of bipolar disorders.
Keywords
- Type
- Chapter
- Information
- Handbook of Liaison Psychiatry , pp. 763 - 794Publisher: Cambridge University PressPrint publication year: 2007
References
, and (2005). Suicide, depression and antidepressants. British Medical Journal, 330, 373–4.Google Scholar
and (1997). Depression in elderly medical inpatients: a metaanalysis of outcomes. Canadian Medical Association Journal, 157, 1055–60.Google Scholar
, , , et al.; Duloxetine Urinary Incontinence Study Group. (2003) Duloxetine versus placebo for the treatment of North American women with stress urinary incontinence. Journal of Urology, 170, 1259–63.Google Scholar
, and (2003). Zuclopenthixol acetate in the treatment of acute schizophrenia and similar serious mental illnesses (Cochrane Review). In: The Cochrane Library, Issue 4. Chichester: John Wiley & Sons.
and (2003). Antidepressants for depression in medical illness (Cochrane Review). In: The Cochrane Library, Issue 4. Chichester: John Wiley & Sons.
, , , et al. Natural Standard Research Collaboration. (2003). St John's wort: a systematic review of adverse effects and drug interactions for the consultation psychiatrist. Psychosomatics, 44, 271–82.Google Scholar
, , , et al. (2004). A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition. Journal of Clinical Psychopharmacology, 24, 62–9.Google Scholar
, , , et al. (2006). Psychotropic drugs and the perioperative period; a proposal for a guideline in elective surgery. Psychosomatics, 47, 8–22.Google Scholar
(2003). Reproductive dysfunction in women with epilepsy. Neurology, 61(Suppl. 2), S27–34.Google Scholar
, , , et al. (2005). CYP2D6 genotype. Antidepressant use and tamoxifen metabolism during adjuvant breast cancer treatment. Journal of the National Cancer Institute, 97, 30–9.Google Scholar
, , , et al. (2003). Antidepressive treatment in patients with temporal lobe epilepsy and major depression: a prospective study with three different antidepressants. Epilepsy Behaviour, 4, 674–9.Google Scholar
, , , et al. (2003). Relapse prevention in schizophrenia with new generation antipsychotics: a systematic review and exploratory meta-analysis of randomized controlled trials. American Journal of Psychiatry, 160, 1209–22.Google Scholar
, , , et al. (1995). A double-blind comparison of moclobemide and doxepin in depressed general practice patients. Acta Psychiatrica Scandinavica, 92, 125–31.Google Scholar
, , , et al. (1999). The Norwegian naturalistic treatment study of depression in general practice (NORDEP) – I: Randomised double-blind study. British Medical Journal, 318, 1180–4.Google Scholar
and (2002). Benefits and risks to mother and infant of drug treatment for postnatal depression. Drug Safety, 25, 903–11.Google Scholar
, , , et al. (2003). Monitoring lithium in breast milk: an individualized approach for breast-feeding mothers. Therapeutic Drug Monitoring, 25, 364–6.Google Scholar
, , ., et al. (2004). Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure. Journal of Clinical Psychiatry, 65, 230–7.Google Scholar
, , , et al. (2003) and the memantine study group. Memantine in moderate-to-severe Alzheimer's disease. New England Journal of Medicine, 348, 1333–41.Google Scholar
and (2003). Review of bupropion for smoking cessation. Drug and Alcohol Review, 22, 203–20.Google Scholar
and (2003). A review of clinical and experimental observations about antidepressant actions and side effects produced by Hypericum perforatum extracts. Phytomedicine, 10, 688–99.Google Scholar
, and (2001). Amoxapine shows an antipsychotic effect but worsens motor function in patients with Parkinson's disease and psychosis. Clinical Neuropharmacology, 24, 242–4.Google Scholar
(2005). College guidelines on electroconvulsive therapy: an update for prescribers. Advances in Psychiatric Treatment, 11, 150–6.Google Scholar
, , , et al. (2004). Olanzapine vs haloperidol: treating delirium in a critical care setting. Intensive Care Medicine, 30, 444–9.Google Scholar
and (2003). Vitamin E for neuroleptic-induced tardive dyskinesia (Cochrane Review). In: The Cochrane Library, Issue 4, Chichester: John Wiley & Sons.
, , , et al. (2004). Psychotropic drug versus psychotropic drug update. General Hospital Psychiatry, 26, 87–105.Google Scholar
, , , et al. (2003). Association between outcome of pregnancy and glycaemic control in early pregnancy in type 1 diabetes: population-based study. British Medical Journal, 325, 1275–6.Google Scholar
and (2004). Risperidone and exaggerated hypotension during a spinal anesthetic. Anesthesia and Analgesia, 98, 240–1.Google Scholar
and (2004). Cholinesterase inhibitor therapies and neuropsychiatric manifestations of Alzheimer's disease. Dementia and Geriatric Cognitive Disorders, 17, 100–8.Google Scholar
- 7
- Cited by